Raffa Wealth Management’s Azora Therapeutics AZR Stock Holding History
Bought
Maintained
Sold
Other funds holding AZR
Raffa Wealth Management's AZR Position: Q3 2026 in Review
Raffa Wealth Management held its Azora Therapeutics (AZR) position steady in Q3 2026 at 83 shares worth $333. The position accounts for ﹤0.01% of the portfolio, ranked #1232.
Raffa Wealth Management first reported a position in AZR in Q1 2019 and has held it in 30 quarters since. The position peaked at $180K in Q3 2021. 22 funds tracked by Wall St. Rank hold AZR as of Q3 2026.
- Raffa Wealth Management held 83 shares of Azora Therapeutics worth $333 as of Q3 2026.
- Raffa Wealth Management left its Azora Therapeutics share count unchanged in Q3 2026.
- Azora Therapeutics made up ﹤0.01% of Raffa Wealth Management's portfolio in Q3 2026, its #1232 holding.
- Raffa Wealth Management first reported a position in Azora Therapeutics in Q1 2019 and has held it in 30 quarters since.
- Raffa Wealth Management's Azora Therapeutics position peaked at $180K in Q3 2021.
- 22 funds tracked by Wall St. Rank held Azora Therapeutics as of Q3 2026.
Based on Raffa Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.